1. ICD-10-CM Codes
›
2. C00-D49
›
3. D3A-D3A
›
4. D3A-
›
5. 2023 ICD-10-CM Diagnosis Code D3A.8

2023 ICD-10-CM Diagnosis Code D3A.8

Other benign neuroendocrine tumors

2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code

• D3A.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
• The 2023 edition of ICD-10-CM D3A.8 became effective on October 1, 2022.
• This is the American ICD-10-CM version of D3A.8 - other international versions of ICD-10 D3A.8 may differ.

• Benign adenoma of middle ear
• Benign neuroendocrine adenoma of middle ear
• Benign neuroendocrine tumor bronchus
• Benign neuroendocrine tumor large intestine
• Benign neuroendocrine tumor lung
• Benign neuroendocrine tumor of appendix
• Benign neuroendocrine tumor of ascending colon
• Benign neuroendocrine tumor of bilateral kidneys
• Benign neuroendocrine tumor of bronchus
• Benign neuroendocrine tumor of cecum
• Benign neuroendocrine tumor of descending colon
• Benign neuroendocrine tumor of duodenum
• Benign neuroendocrine tumor of ileum
• Benign neuroendocrine tumor of jejunum
• Benign neuroendocrine tumor of large intestine
• Benign neuroendocrine tumor of left kidney
• Benign neuroendocrine tumor of liver
• Benign neuroendocrine tumor of lung
• Benign neuroendocrine tumor of pancreas
• Benign neuroendocrine tumor of rectum
• Benign neuroendocrine tumor of right kidney
• Benign neuroendocrine tumor of sigmoid colon
• Benign neuroendocrine tumor of small intestine
• Benign neuroendocrine tumor of stomach
• Benign neuroendocrine tumor of thymus
• Benign neuroendocrine tumor of transverse colon
• Benign neuroendocrine tumor stomach
• Benign neuroendocrine tumor thymus
• Benign neuroendocrine tumor, appendix
• Benign neuroendocrine tumor, ascending colon
• Benign neuroendocrine tumor, bilateral kidneys
• Benign neuroendocrine tumor, cecum
• Benign neuroendocrine tumor, descending colon
• Benign neuroendocrine tumor, duodenum
• Benign neuroendocrine tumor, ileum
• Benign neuroendocrine tumor, jejunum
• Benign neuroendocrine tumor, liver
• Benign neuroendocrine tumor, pancreas
• Benign neuroendocrine tumor, rectum
• Benign neuroendocrine tumor, sigmoid colon
• Benign neuroendocrine tumor, small intestine
• Benign neuroendocrine tumor, transverse colon

• A benign or malignant neoplasm composed of cells of neuroendocrine origin. Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.
• A neoplasm composed of cells of neuroendocrine origin for which the malignancy status has not been established.
• A tumor that forms from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid carcinomas, pheochromocytomas, and neuroendocrine carcinomas of the skin (merkel cell cancer). These tumors may secrete higher-than-normal amounts of hormones, which can cause many different symptoms.
• Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via apud cells), the presence of tumor-associated antigens, and isozyme composition.

• 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc
• 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
• 828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures without cc/mcc
• 829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures with cc/mcc
• 830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedures without cc/mcc
• 843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
• 844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
• 845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc

Convert D3A.8 to ICD-9-CM

• 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
• 2017 (effective 10/1/2016): No change
• 2018 (effective 10/1/2017): No change
• 2019 (effective 10/1/2018): No change
• 2020 (effective 10/1/2019): No change
• 2021 (effective 10/1/2020): No change
• 2022 (effective 10/1/2021): No change
• 2023 (effective 10/1/2022): No change

• Tumor - see also Neoplasm, unspecified behavior, by site
  • neuroendocrine D3A.8

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.